P01911 (DRB1_HUMAN) Homo sapiens (Human)

HLA class II histocompatibility antigen, DRB1 beta chain UniProtKBInterProInteractive Modelling

266 aa; Sequence (Fasta) ; 2 identical sequences: Homo sapiens: D7RIH8, X5DNQ0

Available Structures

101 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Structure of HLA-DR15 with bound alpha3(135-145) peptide
5v4m
 Heteromer
P01903; 		8-219
1×NAG; 1×NAG;
Assess
Structure of HLA-DR1 with bound alpha3(135-145) peptide
5v4n
 Heteromer
P01903; 		8-219
1×NAG;
Assess
HLA-DR1 with CLIP102-120(M107W)
4x5w
 Heteromer
P01903; P04233; 		31-227
Assess
Structure of human MHC class II protein HLA-DR1 carrying an influenza hemagglutinin peptide partial…
4i5b
 Heteromer
P01903; 		31-222
Assess
Crystal Structure of HLA-DR1 with CLIP106-120, flipped peptide orientation
3pgc
 Heteromer
P01903; P04233; 		30-221
Assess
COMPLEX OF THE HUMAN MHC CLASS II GLYCOPROTEIN HLA-DR1 AND THE BACTERIAL SUPERANTIGEN SEB
1seb
 Heteromer
P01552; P01903; 		30-221
Assess
CRYSTAL STRUCTURE OF HLA-DR2 (DRA*0101,DRB1*1501) COMPLEXED WITH A PEPTIDE FROM HUMAN MYELIN BASIC …
1bx2
 Heteromer
P01903; P02686; 		32-222
2×NAG;
Assess
Crystal structure of HLA-DRB1*04:01 with modified alpha-enolase peptide 326-340 (arginine 327 to ci…
5nig
 Heteromer
P01903; P06733; 		30-219
3×MPD; 1×URE; 1×PGE;
Assess
HLA-DR1 with the QAR Peptide
6qzc
 Heteromer
P01903; 		30-219
1×PEG; 4×EDO; 1×GOL; 1×SO4;
Assess
Crystal structure of HLA-DR1/TPI(23-37) complexed with staphylococcal enterotoxin C3 variant 3B2 (S…
1klu
 Heteromer
P01903; P0A0L5; P60174; 		30-219
Assess
HLA class II peptide flanking residues tune the immunogenicity of a human tumor-derived epitope
6hby
 Heteromer
P01903; Q13641; 		30-219
16×EDO; 3×PO4;
Assess
Crystal Structure of HLA-DR1 with CLIP102-120
3pdo
 Heteromer
P01903; P04233; 		30-219
2×GOL; 1×FMT;
Assess
Crystal structure of HLA-DRB1*04:01 in complex with modified alpha-enolase peptide 26-40 with citru…
5jlz
 Heteromer
P01903; P06733; 		30-219
Assess
X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDOMIMETIC AND SEB
1d5z
 Heteromer
P01552; P01903; 		30-219
Assess
Crystal Structure of Staphylococcal Enterotoxin I (SEI) in Complex with a Human MHC class II Molecu…
2g9h
 Heteromer
P01903; P04664; Q52T95; 		30-219
4×SO4; 1×EPE; 2×DIO; 1×ZN;
Assess
Human class II MHC protein HLA-DR1 bound to a designed peptide related to influenza virus hemagglut…
1pyw
 Heteromer
P01903; P03437; P0A0L3; 		30-219
Assess
Structure of MHC class II molecule HLA-DR1 complexed with phosphopeptide MART-1
3l6f
 Heteromer
P01903; Q16655; 		30-219
Assess
Crystal structure of CD4 mutant bound to HLA-DR1
3s5l
 Heteromer
P01730; P01903; P03437; 		30-219
5×GOL;
Assess
HLA-DR1 complexed with a 13 residue HIV capsid peptide
1sjh
 Heteromer
P01903; P0A0L5; P12495; 		30-219
Assess
Crystal Structure of the Complex of the MHC Class II Molecule HLA-DR1 (HA peptide 306-318) with the…
1jwu
 Heteromer
P01903; P0A0L5; 		30-219
Assess
Crystal Structure of the MHC Class II Molecule HLA-DR1 in Complex with the Fluorogenic Peptide, AcP…
2ipk
 Heteromer
A8CDU0; P01903; P0A0L5; 		30-219
Assess
Crystal structure of HLA-DR1/TPI(23-37, Thr28-->Ile mutant) complexed with staphylococcal enterotox…
1klg
 Heteromer
P01903; P0A0L5; P60174; 		30-219
Assess
Crystal structure of F24 TCR -DR11-RQ13 peptide complex
6cql
 Heteromer
A0A0B4J272; A0A5B9; P01903; P04585; 		30-219
2×NAG; 3×MG;
Assess
Crystal structure of CD4 mutant bound to HLA-DR1
3s4s
 Heteromer
P01730; P01903; P03437; 		30-219
1×GOL;
Assess
HLA-DR1 in complex with a synthetic peptide (AAYSDQATPLLLSPR)
1t5w
 Heteromer
P01903; P27705; 		30-219
Assess
Crystal structure of a complete ternary complex between TCR, superantigen, and peptide-MHC class II…
2icw
 Heteromer
A2NTY6; P01738; P01903; Q48898; 		30-219
Assess
X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH DIPEPTIDE MIMETIC AND SEB
1d5x
 Heteromer
P01552; P01903; 		30-219
Assess
HLA-DR1 complexed with a 16 residue HIV capsid peptide bound in a hairpin conformation
1sje
 Heteromer
P01903; P0A0L5; P12495; 		30-219
Assess
immune complex
4y19
 Heteromer
P01308; P01903; 		30-219
1×NAG; 1×NAG; 3×MLI;
Assess
Crystal structure of F5 TCR -DR11-RQ13 peptide complex
6cqn
 Heteromer
A0A0B4J272; A0A0G2JMB4; P01903; P04585; 		30-219
2×NAG; 4×SO4; 2×CL; 1×MG;
Assess
HLA-DR1 in complex with a synthetic peptide (AAYSDQATPLLLSPR) and the superantigen SEC3-3B2
1t5x
 Heteromer
P01903; P0A0L5; P27705; 		30-219
Assess
Crystal structure of HLA-DM bound to HLA-DR1
4fqx
 Heteromer
P01903; P28067; P28068; 		30-219
1×NAG;
Assess
Crystal Structure of the Complex of the MHC Class II Molecule HLA-DR1 (HA peptide 306-318) with the…
1jws
 Heteromer
P01903; P0A0L5; 		30-219
Assess
Crystal structure of HLA_DRB1*04:01 in complex with alpha-enolase peptide 26-40
5lax
 Heteromer
P01903; P06733; 		30-219
Assess
Crystal structure of the MAM-MHC complex
1r5i
 Heteromer
P01903; P11133; Q48898; 		30-219
2×PO4;
Assess
HLA-DR1 with SGP Influenza Matrix Peptide
6qzd
 Heteromer
P01903; P05777; 		30-219
1×PEG; 4×EDO; 1×GOL;
Assess
Crystal Structure of the Complex of the MHC Class II Molecule HLA-DR1(HA peptide 306-318) with the …
1jwm
 Heteromer
P01903; P0A0L5; 		30-219
Assess
HLA-DR1 bound with CLIP peptide
3qxa
 Heteromer
P01903; P04233; 		30-219
Assess
Crystal Structure of HLA-DR1 with CLIP106-120, canonical peptide orientation
3pgd
 Heteromer
P01903; P04233; 		30-219
Assess
Structural basis for recognition of mutant self by a tumor-specific, MHC class II-restricted TCR
2iam
 Heteromer
P01848; P01850; P01903; P60174; 		30-219
Assess
Crystal structure of an immune complex at pH 6.5
4gbx
 Heteromer
P01903; P28067; P28068; 		30-219
3×NAG;
Assess
Mycoplasma arthritidis-derived mitogen complexed with class II MHC molecule HLA-DR1/HA complex in t…
2oje
 Heteromer
P01903; Q48898; Q91LS8; 		30-219
2×PO4;
Assess
Crystal structure of F24 TCR -DR1-RQ13 peptide complex
6cqr
 Heteromer
A0A0B4J272; A0A5B9; P01903; P04585; 		30-219
1×NAG;
Assess
HLA-DR1 with GMF Influenza PB1 Peptide
6qza
 Heteromer
P01903; 		30-219
Assess
immune complex
4y1a
 Heteromer
P01308; P01903; 		30-219
1×NAG;
Assess
Crystal structure of HLA-DRB1*04:01 with the alpha-enolase peptide 326-340
5ni9
 Heteromer
P01903; P06733; 		31-219
1×MRD; 2×URE; 2×MPD;
Assess
Immune Receptor
4md5
 Heteromer
P01903; P08670; 		31-219
1×NAG; 2×NAG; 8×EDO; 1×PGE;
Assess
Immune Receptor
4mdj
 Heteromer
P01903; P08670; 		31-219
1×NAG; 2×NAG; 1×EDO;
Assess
Structure of F11TCR in complex with DR1 MHC Class II presenting PKYVKQNTLKLAT
6r0e
 Heteromer
P01903; P03435; 		30-218
6×EDO; 1×SO4; 2×PEG;
Assess
Immune Receptor
4md4
 Heteromer
P01903; P16112; 		31-219
1×NAG; 2×NAG; 3×EDO;
Assess
Immune Receptor
4mdi
 Heteromer
P01903; P08670; 		31-219
1×NAG; 2×NAG; 1×EDO;
Assess
Crystal structure of DR11 presenting the RQ13 peptide
6cpn
 Heteromer
P01903; P04585; 		31-219
1×NAG; 2×NAG; 8×SO4; 3×NA;
Assess
X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH PEPTIDE AND SEB
1d5m
 Heteromer
P01552; P01903; 		31-219
1×NAG;
Assess
HLA-DRB1 in complex with Histone 2B peptide
6biy
 Heteromer
P01903; Q96A08; 		31-219
2×NAG; 1×B3P;
Assess
HLA-DRB1 in complex with citrullinated fibrinogen peptide
6bij
 Heteromer
P01903; P02675; 		31-219
2×NAG;
Assess
HLA-DRB1 in complex with citrullinated Histone 2B peptide
6biz
 Heteromer
P01903; Q8N257; 		31-219
2×NAG; 1×B3P;
Assess
Crystal structure of Immune Receptor
6nix
 Heteromer
P01903; P02458; 		31-219
3×NAG; 1×B3P;
Assess
Immune Receptor
4md0
 Heteromer
P01903; P08670; 		31-219
1×NAG; 2×NAG;
Assess
Structure of HLA-DR1 with a bound peptide with non-optimal alanine in the P1 pocket
4ov5
 Heteromer
P01903; P04439; 		31-219
Assess
HLA-DRB1 in complex with citrullinated LL37 peptide
6bix
 Heteromer
P01903; P49913; 		31-219
2×NAG;
Assess
HLA-DRB1 in complex with citrullinated Vimentin peptide
6bir
 Heteromer
P01903; P08670; 		31-219
2×NAG;
Assess
Immune Receptor
4mcy
 Heteromer
P01903; P08670; 		31-219
3×NAG; 2×EDO;
Assess
F54C HLA-DR1 bound with CLIP peptide
3qxd
 Heteromer
P01903; P04233; 		31-219
Assess
HLA-DR1 with covalently linked CLIP106-120 in canonical orientation
4ah2
 Heteromer
P01903; P04233; 		30-218
4×GOL;
Assess
HLA-DRB1 in complex with citrullinated fibrinogen peptide
6bil
 Heteromer
P01903; P02675; 		31-219
2×NAG;
Assess
Crystal structure of DR15 presenting the RQ13 peptide
6cpo
 Heteromer
P01903; P04585; 		31-219
2×NAG; 1×PGE; 1×PO4;
Assess
Immune Receptor
4mcz
 Heteromer
P01903; P08670; 		31-219
3×NAG;
Assess
Crystal structure of DR11 presenting the gag293 epitope
6cpl
 Heteromer
P01903; P04585; 		31-219
1×NAG; 2×NAG; 5×SO4; 3×NA; 2×ACT;
Assess
X-RAY CRYSTAL STRUCTURE OF HLA-DR4 COMPLEXED WITH A PEPTIDE FROM HUMAN COLLAGEN II
2seb
 Heteromer
P01552; P01903; P02458; 		31-219
1×NAG;
Assess
HLA-DRB1 in complex with Type II collagen peptide
6bin
 Heteromer
P01903; P02458; 		31-219
1×NAG; 2×NAG;
Assess
Crystal structure of DR1 presenting the RQ13 peptide
6cqj
 Heteromer
P01903; P04585; 		31-219
2×PEG; 1×NAG;
Assess
Crystal structure of F24 TCR -DR15-RQ13 peptide complex
6cqq
 Heteromer
A0A0B4J272; A0A5B9; P01903; P04585; 		31-219
1×NAG; 2×MG; 1×SO4;
Assess
X-ray structure of the complex between staphylococcal enterotoxin B, T cell receptor and major hist…
4c56
 Heteromer
A0A5B9; P01552; P01848; P01903; P03437; 		31-219
Assess
HLA-DRB1 in complex with citrullinated LL37 peptide
6biv
 Heteromer
P01903; P49913; 		31-219
2×NAG;
Assess
HLA-DRB1*15:01 in complex with smith antigen
8tbp
 Heteromer
P01903; P63162; 		31-219
1×NAG;
Assess
HLA-DR1 with covalently linked CLIP106-120 in reversed orientation
4aen
 Heteromer
P01903; P04233; 		32-219
2×GOL;
Assess
Crystal structure of the ternary complex between human T cell receptor, staphylococcal enterotoxin …
2xn9
 Heteromer
P01848; P01850; P01903; P0A0M0; Q03909; 		31-218
4×GOL; 1×NA;
Assess
Crystal Structure of a Complex of a Human alpha/beta-T cell Receptor, Influenza HA Antigen Peptide,…
1j8h
 Heteromer
P01848; P01850; P01903; P03437; 		32-219
1×NAG; 2×NAG;
Assess
CRYSTAL STRUCTURE OF HLA-DR4 COMPLEX WITH PEPTIDOMIMETIC AND SEB
1d6e
 Heteromer
P01552; P01903; 		32-219
Assess
Crystal structure of HLA-DR4 bound to GP100 peptide
4is6
 Heteromer
P01903; P40967; 		31-218
Assess
CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE,…
1fyt
 Heteromer
P01848; P01850; P01903; P03437; 		32-219
2×NAG;
Assess
CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN H IN COMPLEX WITH HUMAN MHC CLASS II
1hxy
 Heteromer
P01903; P0A0M0; Q03909; 		32-219
1×ZN;
Assess
Structure of the Epstein-Barr Virus gp42 Protein Bound to the MHC class II Receptor HLA-DR1
1kg0
 Heteromer
P01903; P03205; P03437; 		32-219
Assess
CRYSTAL STRUCTURE OF THE HUMAN CLASS II MHC PROTEIN HLA-DR1 COMPLEXED WITH AN INFLUENZA VIRUS PEPTI…
1dlh
 Heteromer
P01903; P04664; 		32-219
2×NAG; 4×NAG;
Assess
Crystal structure of a human autoimmune TCR MS2-3C8 bound to MHC class II self-ligand MBP/HLA-DR4
3o6f
 Heteromer
A0A5B9; P01848; P01903; 		31-218
Assess
Structural basis for recognition of mutant self by a tumor-specific, MHC class II-restricted TCR
2ian
 Heteromer
P01848; P01850; P01903; P60174; 		32-219
Assess
Crystal structure of the D227A variant of Staphylococcal enterotoxin A in complex with human MHC cl…
1lo5
 Heteromer
P01903; P0A0L2; 		32-219
Assess
Crystal structure of a complete ternary complex of T cell receptor, peptide-MHC and CD4
3t0e
 Heteromer
A0A5B9; P01730; P01848; P01903; 		31-218
Assess
immune receptor complex
6v1a
 Heteromer
P01903; P02675; 		31-217
3×NAG; 20×GOL; 1×NA;
Assess
immune receptor complex
6v18
 Heteromer
P01903; P02675; 		31-217
2×NAG; 13×GOL;
Assess
HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II HISTOCOMPATIBILITY PROTEIN (EXTRACELLULAR DOMAIN) COMPLEXED…
1aqd
 Heteromer
P01903; P04439; 		33-219
Assess
immune receptor complex
6v19
 Heteromer
P01903; P02675; 		31-217
1×NAG; 9×GOL;
Assess
Structural basis for the recognition of mutant self by a tumor-specific, MHC class II-restricted T …
4e41
 Heteromer
P01903; P60174; 		33-219
2×NA;
Assess
immune receptor complex
6v0y
 Heteromer
P01903; P02675; 		31-217
3×NAG; 4×GOL;
Assess
THE STRUCTURE OF AN INTERMEDIATE IN CLASS II MHC MATURATION: CLIP BOUND TO HLA-DR3
1a6a
 Heteromer
P01903; P04233; 		34-220
2×NAG;
Assess
immune receptor complex
6v13
 Heteromer
P01903; P02675; 		31-217
3×NAG; 5×GOL;
Assess
immune receptor complex
6v15
 Heteromer
P01903; P02675; 		31-217
3×NAG; 4×GOL;
Assess
HLA-DR1 mutant bN82A with covalently linked CLIP106-120(M107W)
4x5x
 Heteromer
P01903; 		31-217
Assess
TCR/HLA-DR2b/MBP-peptide complex
1ymm
 Heteromer
P01850; P01903; P02686; 		32-218
1×NAG;
Assess
TCR complex
2wbj
 Heteromer
P01903; 		32-217
2×NAG; 2×SO4;
Assess
Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101)…
2fse
 Heteromer
P01903; P02458; 		34-219
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
7yxb.1.Bmonomer0.8431-222
91.37
Assess